Aim: The purpose of this prospective, randomized, double-blind study was to evaluate the effect of adding fentanyl to lidocaine 2% with epinephrine 1:80,000 on the success of the inferior alveolar nerve block in mandibular molar teeth with symptomatic irreversible pulpitis. Methodology: 100 healthy adult patients with diagnosis of symptomatic irreversible pulpitis in one of the mandibular molar tooth were selected and randomly divided in two groups of 50 patients each. In the first group (fentanyl group), 0.25 ml of a cartridge of 1.8 ml of 2% lidocaine with 1:80,000 epinephrine solution was drained and the same amount from 50μg/ ml fentanyl solution was added to the cartridge. In the second group (non-fentanyl group) 0.25 ml of a cartridge of 1.8 ml of 2% lidocaine with 1:80,000 epinephrine solution was drained and the same amount from saline solution was added to the cartridge. Each group received two cartridges of prepared soloution with inferior alveolar nerve block injection technique. Access cavity preparation started 15 minautes after injection and after confirming the lip numbness. Success defined as no pain or mild pain on the basis of Heft-Parker visual analog scale during access cavity preparation or initial instrumentation. Data were analyzed by T-test and Chi-square Results: The success rate of inferior alveolar nerve block injection was 58% for Fentanyl group and 46% for Non-Fentanyl group. There was no significant difference between the two groups (P=0.23). Conclusions: The addition of fentanyl to lidocaine 2% with epinephrine 1:80,000 did not increase the success rate of the inferior alveolar nerve block in mandibular molar teeth with symptomatic irreversible pulpitis.

Effect of fentanyl on the success of inferior alveolar nerve block for teeth with symptomatic irreversible pulpitis: a randomized clinical trial / Shekarchizade, N.; Shafa, A.; Tarrahi, M. J.; Nafari, N.; Maglitto, M.; Valletta, A.. - In: GIORNALE ITALIANO DI ENDODONZIA. - ISSN 1121-4171. - 36:1(2022). [10.32067/GIE.2021.35.02.56]

Effect of fentanyl on the success of inferior alveolar nerve block for teeth with symptomatic irreversible pulpitis: a randomized clinical trial

Maglitto M.;Valletta A.
2022

Abstract

Aim: The purpose of this prospective, randomized, double-blind study was to evaluate the effect of adding fentanyl to lidocaine 2% with epinephrine 1:80,000 on the success of the inferior alveolar nerve block in mandibular molar teeth with symptomatic irreversible pulpitis. Methodology: 100 healthy adult patients with diagnosis of symptomatic irreversible pulpitis in one of the mandibular molar tooth were selected and randomly divided in two groups of 50 patients each. In the first group (fentanyl group), 0.25 ml of a cartridge of 1.8 ml of 2% lidocaine with 1:80,000 epinephrine solution was drained and the same amount from 50μg/ ml fentanyl solution was added to the cartridge. In the second group (non-fentanyl group) 0.25 ml of a cartridge of 1.8 ml of 2% lidocaine with 1:80,000 epinephrine solution was drained and the same amount from saline solution was added to the cartridge. Each group received two cartridges of prepared soloution with inferior alveolar nerve block injection technique. Access cavity preparation started 15 minautes after injection and after confirming the lip numbness. Success defined as no pain or mild pain on the basis of Heft-Parker visual analog scale during access cavity preparation or initial instrumentation. Data were analyzed by T-test and Chi-square Results: The success rate of inferior alveolar nerve block injection was 58% for Fentanyl group and 46% for Non-Fentanyl group. There was no significant difference between the two groups (P=0.23). Conclusions: The addition of fentanyl to lidocaine 2% with epinephrine 1:80,000 did not increase the success rate of the inferior alveolar nerve block in mandibular molar teeth with symptomatic irreversible pulpitis.
2022
Effect of fentanyl on the success of inferior alveolar nerve block for teeth with symptomatic irreversible pulpitis: a randomized clinical trial / Shekarchizade, N.; Shafa, A.; Tarrahi, M. J.; Nafari, N.; Maglitto, M.; Valletta, A.. - In: GIORNALE ITALIANO DI ENDODONZIA. - ISSN 1121-4171. - 36:1(2022). [10.32067/GIE.2021.35.02.56]
File in questo prodotto:
File Dimensione Formato  
GIE_21_02_326.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Copyright dell'editore
Dimensione 170.87 kB
Formato Adobe PDF
170.87 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/906869
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact